Each dose should be given for at least 4 weeks before increasing
Retatrutide 10mg -30mg 4.2 out of 5 CAD $100.00 CAD $280.00Price range: CAD $100.00 through CAD $280.00 Retatrutide is a synthetic 39-amino-acid triple receptor agonist supplied lyophilized for in vitro studies of GIP, GLP-1, and glucagon receptor signalling
GlobalData has projected potential sales of $15.6 billion by 2031 if approved, which would make it one of the best-selling drugs in history
A review of GLP-1 agonist studies using the standard dose in high intracranial pressure reported: Patients should be counseled about the high likelihood of nausea and GI upset (diarrhea, vomiting, and constipation, delayed gastric emptying) especially in the first 48 weeks of therapy
If it doesnt, they offer compounded GLP-1s as a more affordable alternative
Pregnancy and breastfeeding require special medical guidance